SML3558
CQ211
≥98% (HPLC)
别名:
1,5-Dihydro-8-(6-methoxy-3-pyridinyl)-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]- 4H -1,2,3-triazolo[4,5-c ]quinolin-4-one, 8‑(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-4H-[1,2,3]triazolo[4,5‑c]quinolin-4-one
登录查看公司和协议定价
所有图片(2)
About This Item
推荐产品
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
white to beige
溶解性
DMSO: 2 mg/mL, clear
储存温度
2-8°C
SMILES字符串
O=C1C2=C(C3=CC(C4=CC=C(N=C4)OC)=CC=C3N1)N(N=N2)C5=CC=C(C(C(F)(F)F)=C5)N6CCNCC6
生化/生理作用
CQ211 is a cell penetrant, selective and highly potent RIOK2 (Right open reading frame kinase 2) inhibitor. CQ211 potently inhibits proliferation of multiple cancer cell lines including MKN-1 and HT-29 cells. It inhibits tumor progression in MKN-1 xenograft model after intraperitoneal administration.
Cell penetrant, selective and highly potent RIOK2 (Right open reading frame kinase 2) inhibitor
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Yifan Ouyang et al.
Journal of medicinal chemistry, 65(11), 7833-7842 (2022-05-19)
RIOK2 is an atypical kinase implicated in multiple human cancers. Although recent studies establish the role of RIOK2 in ribosome maturation and cell cycle progression, its biological functions remain poorly elucidated, hindering the potential to explore RIOK2 as a therapeutic
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门